U.S. Pharma Stock News

Falcon's Beyond Global (FBYD) opened Q3 2025 with total revenue of US$4.1 million and a basic EPS loss of US$0.13, alongside a net income loss of US$4.9 million, setting a mixed tone around top line scale and bottom line pressure. Over recent quarters the company has seen revenue move from US$2.1 million in Q3 2024 to US$4.1 million in Q3 2025, with quarterly EPS swinging between a profit of US$0.49 in Q3 2024 and a loss of US$0.13 in the latest period as profitability remains sensitive to...

T1 Energy (TE) has just closed FY 2025 with Q4 total revenue of US$358.6 million and a basic EPS loss of US$0.70 per share, setting the tone for a year defined by rapid top line expansion alongside ongoing losses. Over the past six quarters, the company has seen total revenue move from US$0 in Q3 2024 to US$2.9 million in Q4 2024, then scale up through FY 2025 to US$53.5 million, US$132.8 million, US$210.5 million and finally US$358.6 million, while basic EPS stayed in loss territory each...

Wondering if DLocal at around US$12.96 is priced for its potential or already baking in a lot of optimism? This article focuses squarely on what the numbers say about value. The stock has returned 0.3% over the last week and 5.9% over the last month, while the 1 year return sits at 57.7% against a negative 7.9% year to date and a 3 year return of 19.9%. Recent price moves are set against ongoing interest in fintech infrastructure and cross border payment platforms. Investors have been...

TruBridge (TBRG) closed out FY 2025 with Q4 revenue of US$87.8 million and a basic EPS loss of US$0.27, while trailing twelve month EPS came in at US$0.30 on revenue of US$346.8 million. The company has seen quarterly revenue move between US$84.7 million and US$90.8 million over the last six reported periods, with basic EPS ranging from a loss of US$4.13 per share on a trailing twelve month basis in 2024 Q3 to positive US$0.30 per share in 2025 Q4, giving investors a clearer read on how...

Chagee Holdings (NasdaqGS:CHA) has posted its Q3 2025 numbers with revenue of C¥3.2b, basic EPS of C¥2.07 and net income of C¥394.2m, giving investors a fresh read on both scale and profitability. Over recent quarters the company has seen revenue move from C¥3.0b in Q2 2024 to C¥3.5b in Q3 2024, then hold around C¥3.3b to C¥3.4b across Q4 2024 and Q1 2025 before landing at C¥3.2b in Q3 2025, while quarterly EPS has ranged from C¥5.88 in Q2 2024 to C¥6.58 in Q1 2025 and C¥2.07 in the latest...

Progress Software (PRGS) has just opened Q1 2026 with total revenue of US$247.8 million and basic EPS of US$0.54, setting the tone for how the year is starting to shape up. Over the past year, the company has seen quarterly revenue move from US$238.0 million in Q1 2025 to US$247.8 million in Q1 2026, while basic EPS went from US$0.25 to US$0.54, and trailing 12 month EPS reached US$1.99 on revenue of US$987.6 million. With trailing net margins now at 8.6%, the latest numbers give investors a...

Sable Offshore (NYSE:SOC) has begun material oil sales through the Santa Ynez Pipeline System. Production has resumed at key offshore platforms, with Platform Harmony currently contributing and additional output expected from Platform Heritage and Platform Hondo. The restart marks a shift from regulatory and planning activity to revenue-generating operations for the company. For readers tracking NYSE:SOC, this move shifts the focus back to physical barrels and pipeline flows rather than...

Adaptive Biotechnologies (NasdaqGS:ADPT) President and COO Julie Rubinstein recently sold shares under a pre-arranged trading plan. The transaction reduced her direct holdings and was executed as a scheduled, non-discretionary insider sale. The sale comes as the company reports clonoSEQ revenue performance and points to a path toward profitability. Adaptive Biotechnologies focuses on immune-driven diagnostics and uses its immune medicine platform to support blood cancer monitoring through...

Intellicheck, Inc. has already reported its full-year 2025 results, with sales rising to US$22.67 million from US$20.00 million and net income improving to US$1.27 million from a US$0.92 million loss a year earlier. The shift from loss to profit, alongside positive basic and diluted earnings per share from continuing operations, underscores a clear improvement in Intellicheck’s operating performance and cost discipline. With Intellicheck’s move to full-year profitability now confirmed, we’ll...

Wondering if JBS at around US$17.34 actually offers value or if the easy gains are gone? This breakdown will help you weigh what the current price might really reflect. The stock has delivered a 15.1% return over the last 7 days, 2.7% over the past 30 days, and 22.3% year to date, which has likely sharpened attention on both its potential and its risks. Recent coverage has focused on JBS as a major player in the global food and meat supply chain, with attention on topics such as industry...

If you are wondering whether SkyWater Technology's recent run still offers value, or if you might be late to the story, this article will walk through what the current price could be implying. The stock trades at US$26.18 after a 10.5% pullback over the last week and 11.1% over the last month, yet it still sits on a 16.7% year-to-date return and a 269.3% return over the past year. These moves come as SkyWater continues to attract attention as a specialized semiconductor foundry, with...

Wondering if Old National Bancorp at around US$21.48 is offering fair value or a potential mispricing opportunity? This article breaks down what the current share price might really be telling you. The stock has seen a 0.3% decline over the past week and a 7.0% decline over the past month, while still sitting on a 4.0% return over the last year and a 65.0% return over three years. This can signal changing views on both growth potential and risk. Recent coverage has focused on Old National...

The United States market has experienced a 3.5% decline over the past week, yet it remains up by 14% over the last year with anticipated earnings growth of 15% annually in the coming years. In this fluctuating environment, identifying stocks that may be trading below their estimated worth can provide opportunities for investors seeking value amidst broader market trends.

Over the last 7 days, the United States market has experienced a 3.5% decline, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often align management interests with shareholders and may offer resilience amid market fluctuations.

Over the last 7 days, the United States market has experienced a 3.5% drop, although it has shown resilience with a 14% rise over the past year and an earnings growth forecast of 15% annually. In this context, dividend stocks that offer consistent payouts and potential for long-term appreciation can be attractive options for investors seeking stability amidst fluctuating market conditions.

Steel Dynamics (NasdaqGS:STLD) announced that long serving directors Richard P. Teets, Jr. and Gabriel L. Shaheen plan to retire from its board at the upcoming annual meeting. The changes will reduce long term board presence and open seats for new directors once shareholders vote at the meeting. Both directors have served during key phases of the company’s development in the steel and metals recycling sector. For you as an investor, this matters because board composition shapes how Steel...

New independent cost impact model evaluates Indivior's extended-release buprenorphine (SUBLOCADE) in U.S. correctional facilities. The model suggests SUBLOCADE, a monthly injectable for opioid use disorder, may meaningfully cut staff time and related costs versus other treatments. Findings, published in a peer reviewed journal, highlight potential operational benefits and treatment access gains for jails and prisons. For investors watching Indivior Pharmaceuticals (NasdaqGS:INDV), this...

Wondering if DRDGOLD at around US$27.65 still offers value, or if most of the easy gains are already behind it? This article walks through what the current price might imply. The stock has returned 1.7% over the last 7 days, while the 30 day return sits at a 28.9% decline, against an 8.8% decline year to date and an 81.5% return over the past year, with a very large 3 year and 226.1% 5 year return. Recent coverage has focused on DRDGOLD as part of broader gold and precious metals...

CIM Real Estate Finance Trust (OTCPK:CMRF) has wrapped up FY 2025 with fourth quarter revenue of US$97.9 million and basic EPS of US$0.07, giving investors a clean snapshot of how the year finished. Over recent periods, revenue has shifted from US$121.4 million in Q3 2024 to US$106.2 million in Q4 2024, then to US$106.4 million in Q1 2025, US$107.2 million in Q2 2025, US$104.5 million in Q3 2025 and US$97.9 million in Q4 2025, while quarterly EPS moved from US$0.02 to an interim loss before...

If you are wondering whether Alphatec Holdings at around US$11 is a bargain or a value trap, the key is to look past the headline share price and into how it stacks up on valuation. The stock has seen a 9.5% decline over the last week, a 19.2% decline over the last 30 days, and is down 47.0% year to date, even though the 1 year return sits at 8.5%. These moves sit against a backdrop of ongoing interest in medical equipment companies, with investors weighing up growth potential in specialist...

We wouldn't blame Hewlett Packard Enterprise Company ( NYSE:HPE ) shareholders if they were a little worried about the...

Investors were underwhelmed by the solid earnings posted by Kanzhun Limited ( NASDAQ:BZ ) recently. We did some digging...

Over the last 7 days, the United States market has experienced a 3.5% drop, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this fluctuating environment, identifying stocks that are potentially undervalued and have notable insider activity can be key to uncovering promising opportunities in the small-cap sector.

Over the last 7 days, the United States market has dropped 3.5%, yet it remains up by 14% over the past year with earnings forecasted to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks requires a focus on companies with strong innovation potential and robust financial health that can capitalize on long-term trends despite short-term fluctuations.